COMMUNIQUÉS West-GlobeNewswire

Power to Decide Announces Lori Adelman as Chief Executive Officer
27/08/2026
Washington, D.C., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Today, Power to Decide announces that Lori Adelman will join the organization as Chief Executive Officer, effective September 14, 2026. Adelman brings nearly two [...]
CalciMedica Announces One-for-Five Reverse Stock Split
27/08/2026
CalciMedica’s Common Stock to Begin Trading on a Post-Split Adjusted Basis on August 31, 2026 LA JOLLA, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- CalciMedica Inc. (“CalciMedica” or the “Company”) (Nasdaq: CALC), a [...]
National Can-RISE Study to Help Close Critical Gaps in Menopause Research
27/08/2026
The first national investigator-led study focused on Canadian women’s experiences of menopause and the menopausal transition is now inviting participants, in partnership with GreenShield and supported by a charitable [...]
L’étude Can-RISE nationale aide à combler les lacunes en recherche sur la ménopause
27/08/2026
En collaboration avec GreenShield et à travers une subvention philanthropique d’Organon, les personnes admissibles sont désormais invitées à prendre part à la première étude nationale menée par des chercheurs reposant [...]
Moleculin CEO, Walter Klemp, Participates in the Virtual Investor “Why Now” On-Demand Conference
27/08/2026
- Video webcast now available here HOUSTON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it participated in the Virtual Investor “Why [...]
Ernexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
27/08/2026
Video webcast now available here CAMBRIDGE, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and [...]
GRI Bio Featured in "Why Now" On-Demand Video Webcast
27/08/2026
Video webcast now available here LA JOLLA, CA, Aug. 27, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company developing innovative therapies for inflammatory, [...]
Akari Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
27/08/2026
Video webcast now available here TAMPA, Fla. and LONDON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel [...]
Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference
27/08/2026
Video webcast now available here ISELIN, N.J., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ ( [...]
Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
27/08/2026
Video webcast now available here SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between [...]
AIM ImmunoTech Participates in the Virtual Investor ‘Why Now’ On-Demand Conference
27/08/2026
Video webcast now available here OCALA, Fla., Aug. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it participated in the Virtual Investor "Why Now" on [...]
POSSIBLE® by Standard Process® Launches Peanut Butter Banana Cacao Snack Bar
27/08/2026
A Whole Food Snack Bar Designed to Support Real Life PALMYRA, Wis., Aug. 27, 2026 (GLOBE NEWSWIRE) -- POSSIBLE ® by Standard Process ® today announced the launch of its new POSSIBLE ® Peanut Butter Banana Cacao Snack [...]
Philips and Imricor launch cardiac interventional MR lab solution, expanding longstanding collaboration
27/08/2026
August 27, 2026 The solution combines Philips' high-performance 1.5T MRI platform and advanced interventional workflow capabilities with Imrico r' s exclusive portfolio of systems and consumables for MR-guided cardiac [...]
Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference
27/08/2026
SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces Myriad management will present at the 21 st [...]
HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System
27/08/2026
Paris, France - August 27, 2026 – HighLife SAS, a medical technology company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral [...]
Orion Corporation to commence acquisition of own shares for its share-based incentive plans
27/08/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 27 AUGUST 2026 at 13.00 EEST Orion Corporation to commence acquisition of own shares for its share-based [...]
IBA publie ses résultats semestriels 2026, et confirme sa trajectoire d’amélioration de la rentabilité
27/08/2026
Louvain-La-Neuve, Belgique, 27 août 2026, 7h00 - IBA (Ion Beam Applications S.A.), annonce aujourd’hui ses résultats consolidés pour le premier semestre 2026, avec une performance conforme aux prévisions pour l’exercice [...]
IBA reports Half Year 2026 results, on track with its improved profitability trajectory
27/08/2026
Louvain-la-Neuve, Belgium, 27 August 2026, 7 a.m. - IBA (Ion Beam Applications S.A.), today announces its consolidated results for the first half of 2026, with performance on track with FY 2026 guidance and continued [...]
Nicox annonce avril 2027 comme date PDUFA pour NCX 470 dans le traitement du glaucome
27/08/2026
Communiqué de presse Nicox annonce avril 2027 comme date PDUFA pour NCX 470 dans le traitement du glaucome La FDA a fixé la date de réponse à l’examen de la NDA dans le cadre du Prescription Drug User Fee Act (PDUFA) au [...]

Pages